- Home
- Publications
- Publication Search
- Publication Details
Title
The VEGF pathway in lung cancer
Authors
Keywords
VEGF, Cancer, Lung, Angiogenesis, Carcinogenesis, Anti-angiogenic, Therapy
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 72, Issue 6, Pages 1169-1181
Publisher
Springer Nature
Online
2013-10-01
DOI
10.1007/s00280-013-2298-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
- (2015) Melchiorre Cervello et al. Oncotarget
- Prognostic Value of Vascular Endothelial Growth Factor Expression in Resected Gastric Cancer
- (2013) Lei Liu et al. Asian Pacific Journal of Cancer Prevention
- Expressions of ER, PR, HER-2, COX-2, and VEGF in Primary and Relapsed/Metastatic Breast Cancers
- (2013) Li Sun et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Markers of Response for the Antiangiogenic Agent Bevacizumab
- (2013) Diether Lambrechts et al. JOURNAL OF CLINICAL ONCOLOGY
- Microvessel density and expression of vascular endothelial growth factor in clinically localized prostate cancer
- (2013) Elżbieta Łuczyńska et al. POLISH JOURNAL OF PATHOLOGY
- The mechanisms that regulate the localization and overexpression of VEGF receptor-2 are promising therapeutic targets in cancer biology
- (2012) Kim R. Kampen ANTI-CANCER DRUGS
- Antiangiogenic Therapy for Glioblastoma
- (2012) Elizabeth R. Gerstner et al. CANCER JOURNAL
- Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
- (2012) B. Sitohy et al. CANCER RESEARCH
- A preclinical and clinical review of aflibercept for the management of cancer
- (2012) Andrew Gaya et al. CANCER TREATMENT REVIEWS
- Targeted therapeutic strategies for the management of renal cell carcinoma
- (2012) Eric A. Singer et al. CURRENT OPINION IN ONCOLOGY
- Sorafenib in melanoma
- (2012) Joanna Mangana et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current status of targeted therapies in advanced gastric cancer
- (2012) Ferdinando De Vita et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- Therapeutic strategies in epithelial ovarian cancer
- (2012) Ayako Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor Vasculature as a Therapeutic Target in Non-small Cell Lung Cancer
- (2012) Jair Bar et al. Journal of Thoracic Oncology
- VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
- (2012) Diether Lambrechts et al. LANCET ONCOLOGY
- Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives
- (2012) Bingxue Shang et al. Frontiers of Medicine
- Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis
- (2011) Masabumi Shibuya BMB Reports
- Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
- (2011) R A Smith et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer
- (2011) Ravi Salgia CANCER
- Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
- (2011) Samar Masoumi Moghaddam et al. CANCER AND METASTASIS REVIEWS
- Targeted Therapies for Lung Cancer
- (2011) Jill E. Larsen et al. CANCER JOURNAL
- Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)
- (2011) C.P. Belani et al. CANCER TREATMENT REVIEWS
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Safety Profile and Tolerability of Antiangiogenic Agents in Non–Small-Cell Lung Cancer
- (2011) Shirish M. Gadgeel Clinical Lung Cancer
- Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer
- (2011) A. D. Karatzanis et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- ENDOCRINE TUMOURS: Approach to the patient with advanced differentiated thyroid cancer
- (2011) M Schlumberger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- New Insights into the Biology of Renal Cell Carcinoma
- (2011) Lianjie Li et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Developmental antiangiogenic agents for the treatment of Non-Small Cell Lung Cancer (NSCLC)
- (2011) George R. Blumenschein INVESTIGATIONAL NEW DRUGS
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck
- (2011) Shahzad Raza et al. Recent Patents on Anti-Cancer Drug Discovery
- Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies
- (2011) Ramon Andrade de Mello et al. Recent Patents on Anti-Cancer Drug Discovery
- Novel targeted agents for the treatment of bladder cancer: translating laboratory advances into clinical application
- (2011) Xiaoping Yang et al. International Braz J Urol
- Angiogenesis: A Target in Solid Tumors, Also in Leukemia?
- (2011) T. Schmidt et al. Hematology-American Society of Hematology Education Program
- Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer
- (2010) Peter B. Vermeulen et al. CANCER
- microRNAs and lung cancer: tumors and 22-mers
- (2010) Liqin Du et al. CANCER AND METASTASIS REVIEWS
- Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
- (2010) Beate M. Lichtenberger et al. CELL
- Targeting Vascular Endothelial Growth Factor Receptor in Thyroid Cancer: The Intracellular and Extracellular Implications
- (2010) S. M. Keefe et al. CLINICAL CANCER RESEARCH
- Risk/benefit profile of bevacizumab in metastatic colon cancer: A systematic review and meta-analysis
- (2010) Elena Galfrascoli et al. DIGESTIVE AND LIVER DISEASE
- Current data on predictive markers for anti-angiogenic therapy in thoracic tumours
- (2010) N. Reinmuth et al. EUROPEAN RESPIRATORY JOURNAL
- Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway
- (2010) Grzegorz Korpanty et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis
- (2010) Ping Zhan et al. Journal of Thoracic Oncology
- Quantifying the Proteolytic Release of Extracellular Matrix-Sequestered VEGF with a Computational Model
- (2010) Prakash Vempati et al. PLoS One
- Concise Review: Vascular Stem Cells and Tumor Angiogenesis
- (2010) Juan M. Melero-Martin et al. STEM CELLS
- Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors
- (2010) Susan A. J. Vaziri et al. Current Oncology Reports
- Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies
- (2010) Michael Medinger et al. Journal of Oncology
- Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor
- (2009) Jerry Y. Hsu et al. BIODRUGS
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
- (2009) S J Schoenleber et al. BRITISH JOURNAL OF CANCER
- Angiogenesis in pre-malignant conditions
- (2009) Marius Raica et al. EUROPEAN JOURNAL OF CANCER
- Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors
- (2009) Woo-Young Kim et al. FEBS Journal
- Tumor Angiogenesis in Melanoma
- (2009) Alexander G. Marneros HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis
- (2009) Barbara Bonnesen et al. LUNG CANCER
- MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo
- (2009) Bo Liu et al. LUNG CANCER
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
- (2009) L. Jain et al. MOLECULAR CANCER THERAPEUTICS
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Combined Inhibition of the VEGFR and EGFR Signaling Pathways in the Treatment of NSCLC
- (2009) N. A. Pennell et al. ONCOLOGIST
- Stroma–epithelium crosstalk in prostate cancer
- (2008) Yi-Nong Niu et al. ASIAN JOURNAL OF ANDROLOGY
- Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
- (2008) D. D. Hu-Lowe et al. CLINICAL CANCER RESEARCH
- Inflammation in lung carcinogenesis: New targets for lung cancer chemoprevention and treatment
- (2008) Jay M. Lee et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
- (2008) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting vasculature in urologic tumors: Mechanistic and therapeutic significance
- (2007) Shinichi Sakamoto et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More